Global Biomarkers Market to Reach $173.8 Billion by 2030, Driven by Personalized Medicine, Drug Development, and Diagnostics

By -

 

Overview

Biomarkers, or biological markers, are measurable indicators of biological states or conditions. They are widely used in diagnostics, disease monitoring, and drug development to assess disease progression and treatment effects. Biomarkers include molecules, genes, proteins, and other substances found in tissues, blood, or body fluids. Their importance spans multiple applications, including companion diagnostics, personalized medicine, and clinical research. With advancements in imaging technologies, biomarkers help healthcare professionals visualize data, design effective treatment plans, and identify therapeutic targets.

The global biomarkers market, valued at $81.7 billion in 2024, is projected to reach $173.8 billion by 2030, growing at a CAGR of 13.4% from 2024 to 2030. This growth is fueled by an increasing incidence of chronic diseases, rising demand for precision medicine, and technological advancements in genomics, proteomics, and high-throughput screening.

Market Drivers

The biomarkers market is experiencing rapid expansion due to several key factors:

  • Rising prevalence of chronic diseases such as cancer, cardiovascular disorders, neurological conditions, and diabetes.

  • Advancements in liquid biopsy technology, point-of-care testing, and multi-biomarker panels improving specificity and sensitivity in diagnostics.

  • Increased adoption of personalized medicine, facilitating targeted therapies and improving treatment outcomes.

  • Government initiatives and growing investments in biotechnology and healthcare R&D.

  • Aging population and growing use of minimally invasive diagnostic techniques.

  • Integration of AI and machine learning in bioinformatics, enhancing biomarker discovery and analysis.

Regional Market Insights

North America

  • Largest market, accounting for 43.2% of the global share in 2024.

  • Growth driven by strong biotechnology and pharmaceutical sectors, high R&D investments, and government support.

  • FDA regulations and increasing incidence of chronic diseases promote biomarker adoption in diagnostics and drug development.

Asia-Pacific

  • Fastest-growing region, projected to expand at a CAGR of 15.3% (2024-2030).

  • Growth fueled by rising healthcare expenditures, chronic disease prevalence, and government investments in biopharmaceutical research.

  • China and India emerge as key players in biomarker research and diagnostic advancements.

Market Segmentation

By Biomarker Type

  • Safety Biomarkers – Largest segment (38.6% market share in 2024), vital in clinical trials for detecting toxicity and ensuring patient safety.

  • Efficacy Biomarkers – Expected to grow at a CAGR of 14.9%, crucial for assessing drug effectiveness and patient responses, particularly in precision medicine.

By Technology

  • Omics Technologies dominate the market (53% share in 2024), including genomics, proteomics, metabolomics, and transcriptomics, essential for biomarker discovery.

  • Bioinformatics is the fastest-growing technology segment (15.3% CAGR), driven by AI and machine learning applications in biomarker analysis.

By Omics Type

  • Genomics leads the omics market (41% share in 2024) and is expected to grow at a 14.5% CAGR, supported by advancements in Next-Generation Sequencing (NGS).

  • Proteomics remains essential for drug discovery and disease diagnosis, utilizing techniques like mass spectrometry and liquid chromatography.

By Disease Indication

  • Cancer dominates with a 42.5% market share in 2024, driven by increasing cancer cases and demand for precision medicine.

  • Neurological Diseases expected to grow at 15.3% CAGR, supported by research into Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.

By Application

  • Drug Discovery & Development holds the largest share (31.4%), aiding pharmaceutical companies in identifying drug targets and streamlining clinical trials.

  • Diagnostics expected to grow at 14.8% CAGR, fueled by demand for early disease detection and improved diagnostic accuracy.

Future Outlook

Industry Experts, Inc. projects the biomarkers market is set for robust growth, driven by increased investments in precision medicine, advanced technologies in genomics and proteomics, and the need for more effective and personalized healthcare solutions. As AI and digital biomarkers become more integrated into medical research and diagnostics, the market will continue to evolve, offering new opportunities for early disease detection, targeted therapies, and cost-efficient healthcare solutions worldwide.

Comments

Post a Comment

Popular posts from this blog

Demand for Europium to Reach US$373.3 million by 2030 Fostered by Phosphors and Consumer Electronic Applications

By -
Image
Industry Experts, Inc., has released its latest report on Europium Market , which projects the demand for the same to reach US$373.3 million by 2030 from an estimated US$267.1 million in 2024 at a CAGR of 5.7% between the two years. The demand for Europium in the global market is primarily being driven by a number of factors that include increasing demand of phosphors in various applications for making high-quality displays that offer higher cooling, energy efficiency and brightness in products, such as OLEDs & LCDs, which are used in televisions, smart phones, wearables  and other electrical & electronic equipment. Technological advancements have enhanced the methods of extracting, purifying and separating europium from other ores, thereby positively impacting its availability to manufacturers. Heavy investments in R&D for improving performance and overcoming supply challenges of this metal have determined the global market in yielding innovative solutio...
Read more

Oil & Gas Fuels Demand for Duplex Stainless Steel and Global Market to Reach $6 billion by 2030

By -
Image
Industry Experts, Inc., has released its latest report, on Duplex Stainless Steel market, which projects the demand for the same to reach US$6 billion by 2030 from an estimated US$4.4 billion in 2024 at a CAGR of 5.4% between the two years. Some of the factors instrumental in driving demand for Duplex Stainless Steel include its widespread use in the oil & gas industry in the form of pipes & tubes. Comprising an almost equal proportion of austenitic and ferritic steels makes this variety of stainless steel very strong and highly resistant to corrosion, owing to which its application across various important end-use sectors has been growing rapidly.  The construction & infrastructure industry is another major consumer of Duplex Stainless Steels, as they are ideal for making bridges and other infrastructure projects. Apart from this, the chemical processing industry, subject to extreme operating environments, also makes extensive use of Duplex Stainless Ste...
Read more

Copper Demand to Reach US$368.8 B by 2030 Propelled by the Wide Range of Applications of the Metal Across Sectors

By -
Image
Industry Experts, Inc., has released its latest report, on Copper , which projects the demand for Copper to reach US$368.8 billion by 2030 from an estimated US$269 billion in 2024 at a CAGR of 5.4% between the two years. The use of copper and its alloys is quite extensive, contributing significantly to economic development. Major end-user sectors of this vital element include transportation, construction, consumer products, electrical & electronics and industrial machinery. The global demand for copper has been maintaining a steady growth, as statistics reveal a 300% growth in the use of refined copper over the last five decades across the industries mentioned above, reaching about 26.5 million tons in 2023. Other than being used in its primary form, copper is also among the most recycled materials, owing to which the market for secondary copper has been posting considerable growth. With an estimated share of about 41% in 2024, Asia-Pacific is the largest global marke...
Read more